The Latest SPAC News and Rumors: October 7, 2022

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Polestar warns of slow recovery from lockdown, CVS in exclusive talks to buy Cano Health, and Slack’s backers warn SCOTUS of hit to capital markets from direct listing case

Polestar Warns Slow Recovery From Lockdown Dragged on Results

Polestar Automotive Holding (NASDAQ:PSNY) said supply issues that lingered after China’s Covid lockdowns earlier this year will weigh on results the electric-car maker is releasing next month, though it’s sticking with its full-year deliveries target.

The Volvo Car AB plant in Luqiao, China, that produces the Polestar 2 was hamstrung or stopped entirely for almost eight weeks in the spring, and the company is still scrambling to get enough computer chips and other essential parts. Polestar handed over just 9,215 of those sedans to buyers during the quarter ended Sept. 30. The company will need to more than double that figure this quarter to reach its 50,000 vehicle target for the year, as it’s delivered 30,400 thus far.

CVS Is in Exclusive Talks to Buy Cano Health

CVS Health Corp. (NYSE:CVS) is in exclusive talks to buy Cano Health Inc. (NYSE:CANO), the health-care provider backed by billionaire Barry Sternlicht, according to people familiar with the matter.

CVS is currently conducting due diligence on the Miami, Florida-based company, said the people, who asked to not be identified because the matter isn’t public. There is no certainty a deal will be reached, in part because Humana Inc. has a right of first refusal should Cano find a buyer under an agreement they made in 2019, said the people.

Cano Health listed on the NYSE last year through a merger with a SPAC sponsored by Sternlicht, who leads Starwood Capital Group Management.

Slack’s backers warn SCOTUS of hit to capital markets from direct listing case

Defenders of business software company Slack Technologies LLC told the U.S. Supreme Court this week that if the justices do not step in to overturn a ruling that allows investors in a 2019 direct listing to sue Slack for alleged misrepresentations, then every company contemplating a public offering – whether through a de-SPAC deal, an IPO or a direct listing – could face expanded liability in Securities Act class actions.